{"id":"W4386271025","doi":"10.1016/s2152-2650(23)00863-7","title":"POSTER: MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Dose-Expansion Phase of the CC-92480-MM-001 Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Alberta Health Services; University of Calgary; McGill University; Institute of Cancer Research; McGill University Health Centre","funders":"","keywords":"Dexamethasone; Medicine; Refractory (planetary science); Multiple myeloma; Oncology; Internal medicine; Phase (matter); Materials science; Chemistry; Composite material","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001036991,0.0009256265,0.001268314,0.0001902654,0.0003356921,0.001069866,0.0005967984,0.0009614826,0.01312566],"category_scores_gemma":[0.0009299855,0.0002772044,0.001429193,0.0002314468,0.0003958085,0.0006444929,0.0004146486,0.003958617,0.002350137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006816549,"about_ca_system_score_gemma":0.0008562864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001290647,"about_ca_topic_score_gemma":0.003048904,"domain_scores_codex":[0.9997124,0.0001295202,0.00001236551,0.00004803053,0.00002714786,0.00007042345],"domain_scores_gemma":[0.9995413,0.00009703696,0.00007806119,0.00002632587,0.00002542999,0.0002319598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6621873,0.006934333,0.002598758,0.001767965,0.002513305,0.000130945,0.0001636405,0.002155143,0.01270466,0.0008044665,0.05456539,0.2534742],"study_design_scores_gemma":[0.7782108,0.1447937,0.0287511,0.0003938575,0.002781626,0.0003066597,0.0001362134,0.001401493,0.004920143,0.001173059,0.03703588,0.00009544624],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9042522,0.04695471,0.001056936,0.01320906,0.0031287,0.001607049,0.008698052,0.0006413884,0.02045202],"genre_scores_gemma":[0.941331,0.01558806,0.002042353,0.00856696,0.001535835,0.0007483599,0.006783991,0.0001378955,0.02326556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01312566,"threshold_uncertainty_score":0.04390973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08768596957785604,"score_gpt":0.3801710769708092,"score_spread":0.2924851073929531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}